HOME >> MEDICINE >> NEWS
Orqis receives FDA approval to expand clinical trial of Cancion CRS therapy to 40 centers

Orqis Medical Corp. today announced that the U.S. Food and Drug Administration has approved an expansion of the Cancion CRSTM clinical trial from eight to 40 medical centers nationwide, accelerating the trial's recruitment and enrollment efforts.

The Cancion CRS therapy is a percutaneous cardiac recovery system being studied for its ability to create a "rest-to-recovery" environment for congestive heart failure (CHF) patients. Enrollment in the Multicenter trial of the Orqis Medical CRS for the ENhanced Treatment of CHF, Unresponsive to Medical Therapy (MOMENTUM) trial began in September of this year.

"We've worked with the FDA to develop an effective protocol for the MOMENTUM trial and are gratified that we can now ramp up to a full complement of sites," said Marvin A. Konstam, M.D., Medical Director of Orqis Medical and Chief of Cardiology at Tufts-New England Medical Center in Boston. "This puts us yet another step closer to our goal of documenting the value that the Cancion therapy can bring to patients with heart failure."

Heart failure is the deterioration of the heart's ability to pump blood throughout the body and adequately perfuse the major organs. According to the AHA, some five million Americans have heart failure and an additional 550,000 are diagnosed annually. The single most expensive diagnosis in the U.S. health care system, acutely decompensated heart failure, represents 1 million primary and 2.5 million secondary hospital admissions annually.

About The Cancion CRS Therapy
A breakthrough discovery in hemodynamics -- the simple supplementation of blood flow specifically in the descending aorta -- led to the development of the Cancion CRS therapy, which centers on the novel use of a blood pump and proprietary peripheral access to the circulatory system.

The Cancion CRS increases blood flow in the descending aorta without t
'"/>

Contact: Kimberly Goolsby
kimberly@goolsbygroup.com
949-464-0187
Goolsby Group
10-Jan-2005


Page: 1 2

Related medicine news :

1. New data on Orqis Medicals Cancion CRS to be reported at ACC
2. UIC professor receives international humanitarian award
3. Mailman School of Public Health receives Manhattan Tobacco Cessation Center grant
4. Epidemiologist Trichopoulos receives $5.8 million Department of Defense Innovator Award
5. GlaxoSmithKline receives unanimous favorable recommendation by FDA Advisory Committee for Boostrix
6. NYU Child Study Center receives grant from the American Red Cross September 11 recovery program
7. Northwestern Memorial Hospital receives $10 million commitment to support preeminent heart program
8. American Academy of Neurology program receives Grassroots Award
9. Mayo Clinic Cancer Center receives SPORE grant for brain cancer research from NCI
10. Pfizers antifungal medicine VFEND receives FDA approval
11. Shire receives US FDA approval of EQUETRO (TM) for bipolar disorder

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/14/2019)... ... January 14, 2019 , ... Modere (the “Company”), ... with a presence worldwide, today announced that it built on 2017’s growth momentum, ... grew by double-digits in North America, by more than five times in Europe ...
(Date:1/14/2019)... ... January 14, 2019 , ... The ... availability of VARIZIG® (Varicella Zoster Immune Globulin [Human]) for post-exposure prophylaxis of ... the update, the CDC notes that VARIZIG is commercially available from a broad ...
(Date:1/14/2019)... ... 2019 , ... Dr. Kaveh Kanani D.D.S . is the head of Around the Corner ... general dentist has recently unveiled an inventive method of inserting dental implants. , ... is missing for an extended period of time, the jawbone that used to hold the ...
(Date:1/13/2019)... ... January 12, 2019 , ... On December 13th, The Pennsylvania ... hosted a continuing education (CEU) event entitled, Can You Hear Me Now? Creating ... a series of talks to help develop and cultivate the relationship between mentors ...
(Date:1/11/2019)... ... 11, 2019 , ... In Partnership with the Smiles for Everyone Foundation ... at its Burleson, TX office on February 9. , Dental services provided ... and extractions . For more information, please visit the Monarch Dental website ...
Breaking Medicine News(10 mins):
(Date:1/10/2019)... (PRWEB) , ... January 10, 2019 , ... ... wellness company providing nutrition and lifestyle solutions, will crown the U.S. winner of ... Period’s 15 finalists include: Andrea Carrara of Palm Beach, Florida; Barbara Lingle of ...
(Date:1/8/2019)... , ... January 08, 2019 , ... ... been designated as a UroLift® Center of Excellence. The designation recognizes that Dr. ... System and demonstrated a commitment to exemplary care for men suffering from symptoms ...
(Date:1/8/2019)... ... January 08, 2019 , ... Date aired: August 13th, 2018 , Guest: ... excessive evaporation of the tear film, which is naturally 99 percent water, and it ... says water researcher Sharon Kleyne, host of the internationally syndicated radio program, The Sharon ...
Breaking Medicine Technology:
Cached News: